Drug Research
UCB, ConfometRx sign drug discovery research deal
Belgium-based biopharmaceutical company UCB has signed a research deal with ConfometRx for the discovery of new drugs. Under the deal,...
Drug Research
Dr. Reddy’s introduces Desloratadine ODT in US
Dr. Reddy's Laboratories has received the FDA approval and introduced Desloratadine orally disintegrating tablets (ODT) in 2.5mg and 5mg strengths in the US. ...
Drug Research
Stellar Biotechnologies develops aquaculture system for KLH manufacturing
Stellar Biotechnologies has developed a controlled, commercial-scale aquaculture system for fully sustainable Keyhole Limpet Hemocyanin (KLH) manufacturing. The land-based aquaculture...
Drug Research
Synthon opens new GMP antibody-drug conjugate production facility in...
Synthon Biopharmaceuticals has opened a GMP antibody-drug conjugate (ADC) production facility in Nijmegen. The Nijmegen facility will produce ADCs, which...
Drug Research
Paladin introduces grass pollen allergy medication in Canada
Specialty pharmaceutical company Paladin Labs has introduced first allergen immunotherapy tablet, Oralair, against grass pollen allergies in Canada. The sublingual...
Drug Research
Aptar Pharma names Jean-Marc Pardonge as prescription division new...
Aptar Pharma, a subsidiary of Aptargroup, has named Jean-Marc Pardonge as the new president for the company's prescription division. The...
Drug Research
FDA approves ThromboGenics vitreomacular adhesion therapy
The USFDA has approved ThromboGenics' Jetrea (ocriplasmin) for the treatment of symptomatic vitreomacular adhesion (VMA). The approval was based on...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.